Disclosure Of Cash Flow Statement [Text Block]

BerGenBio - Filing #2615544

Concept As at
2021-12-31
As at
2020-12-31
As at
2019-12-31
Disclosure of cash flow statement [text block]
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
436,646,000 NOK
721,641,000 NOK
253,586,000 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.